Imagion Biosystems, Ltd. (ASX: IBX) has secured AU$3.75M (US$2.59M) in new capital following FDA clearance of its investigational new drug ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE